Medicare Enrolled
Dr. Cesar Hidalgo, MD
Neurology · Rochester Hills, MI
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hidalgo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hidalgo?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hidalgo
Dr. Cesar Hidalgo is a neurology specialist in Rochester Hills, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Hidalgo performed 1,400 Medicare services across 1,073 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hidalgo received a total of $10,095 from 58 pharmaceutical and/or device companies across 492 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hidalgo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 12% volume in MI
$10,095 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,400
Medicare services
Top 12% in MI for neurology
1,073
Unique beneficiaries
$119
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~70 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
391 | $93 | $250 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
153 | $76 | $200 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
140 | $68 | $200 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
113 | $297 | $741 |
| New patient office visit, complex (60-74 min) | 113 | $161 | $450 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
111 | $141 | $475 |
| Auditory brainstem response test A test that measures how the brain responds to sound to help diagnose nervous system disorders. The results are interpreted and reported by a medical professional. |
58 | $68 | $300 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
48 | $163 | $500 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
43 | $135 | $300 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
42 | $64 | $150 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
39 | $41 | $125 |
| Balance and posture test A test to evaluate a patient's balance and posture. This assessment measures stability and body alignment. |
31 | $38 | $300 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
26 | $351 | $900 |
| Placement of skin electrodes and measurement of stimulated sites in arms Skin electrodes are placed on the arms to measure the response to stimulation at specific sites. |
18 | $142 | $400 |
| Vestibular function test with thermal irrigation A test that assesses balance by irrigating both ears with warm and cool fluids to evaluate inner ear function. |
17 | $32 | $100 |
| Balance testing with recording A procedure to evaluate balance function by recording the results during testing. |
17 | $87 | $200 |
| Nerve conduction studies, 7-8 tests A series of 7 to 8 nerve conduction tests to evaluate how well nerves are sending signals to muscles. |
16 | $140 | $500 |
| Placement of skin electrodes and measurement of stimulated sites in legs This procedure involves placing skin electrodes on the legs and measuring the sites where stimulation is applied. |
13 | $123 | $400 |
| Vestibular function test using rotating chair This test evaluates eye movement and balance function by having the patient sit in a rotating chair. It helps assess how the inner ear and brain coordinate to maintain stability. |
11 | $100 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$10,095
Total received (2018-2024)
Avg $1,442/year across 7 years
Top 22% in MI for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
492
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,875 (97.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$220 (2.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,057
2023
$1,711
2022
$2,062
2021
$1,709
2020
$976
2019
$932
2018
$649
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$403
UCB, Inc.
$301
Eisai Inc.
$171
ARGENX US, INC.
$144
AstraZeneca Pharmaceuticals LP
$125
Biogen, Inc.
$108
Lilly USA, LLC
$88
Alexion Pharmaceuticals, Inc.
$84
PFIZER INC.
$79
Lundbeck LLC
$59
EMD Serono, Inc.
$58
ACADIA Pharmaceuticals Inc
$56
Genentech USA, Inc.
$52
Celgene Corporation
$47
CATALYST PHARMACEUTICALS, INC.
$41
Azurity Pharmaceuticals, Inc.
$37
SK Life Science, Inc.
$33
Neurocrine Biosciences, Inc.
$31
Amgen Inc.
$30
HOSPIRA, INC.
$22
Novartis Pharmaceuticals Corporation
$21
Supernus Pharmaceuticals, Inc.
$18
Teva Pharmaceuticals USA, Inc.
$18
Neurelis, Inc.
$16
Kyowa Kirin, Inc.
$15
Top 3 companies account for 42.5% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,230
UCB, Inc.
$713
GENZYME CORPORATION
$676
Novartis Pharmaceuticals Corporation
$527
Allergan, Inc.
$476
ARGENX US, INC.
$431
Neurelis, Inc.
$374
Celgene Corporation
$367
ACADIA Pharmaceuticals Inc
$317
Lilly USA, LLC
$309
Amgen Inc.
$309
Teva Pharmaceuticals USA, Inc.
$270
AstraZeneca Pharmaceuticals LP
$263
EMD Serono, Inc.
$240
SK Life Science, Inc.
$240
Janssen Pharmaceuticals, Inc
$233
Lundbeck LLC
$232
Amneal Pharmaceuticals LLC
$199
Allergan Inc.
$196
Biogen, Inc.
$196
Eisai Inc.
$192
Adamas Pharmaceuticals, Inc.
$176
PFIZER INC.
$173
AbbVie Inc.
$168
Alexion Pharmaceuticals, Inc.
$123
CATALYST PHARMACEUTICALS, INC.
$115
Xeris Pharmaceuticals, Inc.
$109
Abbott Laboratories
$108
Horizon Therapeutics plc
$102
Corium, LLC
$87
Acorda Therapeutics, Inc
$83
Kyowa Kirin, Inc.
$75
Genentech USA, Inc.
$67
Biohaven Pharmaceutical Holding Company Ltd.
$65
Supernus Pharmaceuticals, Inc.
$65
Azurity Pharmaceuticals, Inc.
$54
E.R. Squibb & Sons, L.L.C.
$51
Neurocrine Biosciences, Inc.
$48
Sunovion Pharmaceuticals Inc.
$44
Bayer HealthCare Pharmaceuticals Inc.
$35
Arbor Pharmaceuticals, Inc.
$33
CSL Behring
$33
Bausch Health US, LLC
$24
Catalyst Pharmaceuticals, Inc.
$24
Avanir Pharmaceuticals, Inc.
$23
HOSPIRA, INC.
$22
Medtronic USA, Inc.
$22
UPSHER-SMITH LABORATORIES LLC
$20
Aprecia Pharmaceuticals, LLC
$19
Grifols USA, LLC
$19
Mylan Pharmaceuticals Inc.
$18
EISAI INC.
$17
Strongbridge US INC.
$15
Vertical Pharmaceuticals, LLC
$15
Biohaven Pharmaceuticals, Inc.
$14
US WorldMeds, LLC
$14
ARBOR PHARMACEUTICALS, INC.
$13
JAZZ PHARMACEUTICALS INC.
$12
Top 3 companies account for 26.0% of all-time payments
Associated products mentioned in payments ›
ADLARITY · ADUHELM · AFINITOR · AGAMREE · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVYCAZ · Adlarity · Aimovig · Amplatzer Cardiac Plug · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRILINTA · Betaseron · Briviact · COMIRNATY · DALVANCE · DUOPA · EMGALITY · Enspryng · FASENRA · FIRDAPSE · FYCOMPA · Fycompa · GILENYA · GOCOVRI · Gamunex-C · Glatiramer Acetate · HORIZANT · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KEVEYIS · KISUNLA · LEMTRADA · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · OSMOLEX ER · Ocrevus Zunovo · Ongentys · POMPE - DISEASE · Ponvory · QULIPTA · Qelbree · REXULTI · RYTARY · Rebif · Rystiggo · SOLIRIS · SUNOSI · Solitaire · Spritam · TOSYMRA · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VRAYLAR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
247
Per 100K population
19.4
County median income
$95,296
Nearest hospital
ASCENSION PROVIDENCE ROCHESTER HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hidalgo is a clinical cardiology specialist, with above-average Medicare volume (top 12% in MI), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hidalgo experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Hidalgo performed 391 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hidalgo receive payments from pharmaceutical companies?
Yes. Dr. Hidalgo received a total of $10,095 from 58 companies across 492 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hidalgo's costs compare to other neurologists in Rochester Hills?
Dr. Hidalgo's average Medicare payment per service is $119. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hidalgo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Rochester Hills
Browse neurologists in Rochester Hills ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in MI
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in MI
Which MI neurologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology